Home > Cashflow Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹317 Cr₹261 Cr₹237 Cr₹60 Cr₹189 Cr

What is the latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES ?

The latest Cash Flow from Operating Activities ratio of NEULAND LABORATORIES is ₹317 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹317 Cr
Mar2024₹261 Cr
Mar2023₹237 Cr
Mar2022₹60 Cr
Mar2021₹189 Cr

How is Cash Flow from Operating Activities of NEULAND LABORATORIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹317 Cr
21.52
Mar2024 ₹261 Cr
10.10
Mar2023 ₹237 Cr
292.81
Mar2022 ₹60 Cr
-68.11
Mar2021 ₹189 Cr -

Compare Cash Flow from Operating Activities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹17,583.0 Cr -2.9% 14.8% 64.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,551.0 Cr 0.4% 1.8% 4.5% Stock Analytics
DIVIS LABORATORIES ₹175,704.0 Cr -1.1% 0.1% 45.6% Stock Analytics
CIPLA ₹123,675.0 Cr 3.8% 1.2% -1.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,925.0 Cr 2.2% 11.7% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,626.0 Cr 1.4% -3.3% -7.2% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-2.9%

14.8%

64.8%

SENSEX

-0.4%

-1.6%

1.3%


You may also like the below Video Courses